How should we use prokinetic drugs in patients who are intolerant to enteral feeding?
Asai
Takashi
T
D016638:Critical Illness / Q000628:therapy*; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D004750:Enteral Nutrition / Q000009:adverse effects*; D004917:Erythromycin / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use*
D018492:Dopamine Antagonists; D005765:Gastrointestinal Agents; D004917:Erythromycin; D008787:Metoclopramide